FDA Inspection 663189 — Quintiles IMS Ireland Limited
The FDA completed an inspection of Quintiles IMS Ireland Limited on May 21, 2010 in Dublin 3. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 21, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dublin 3 (Ireland)
Additional Details
Sponsor, Contract Research Organization